Phillip B. Donenberg

TSHA

Phillip B. Donenberg serves as Director at Taysha Gene Therapies, Inc. (TSHA). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

2 trades

$123.3K

Total Sells

0 trades

$0.00

Net Position

Net Buyer

$123.3K

Companies Traded

TSHA

Active Period

Feb 2022 – Aug 2023

2 total trades

Most Recent

Buy TSHA

Aug 16, 2023 · $100.0K

Phillip B. Donenberg's Insider Trading at Taysha Gene Therapies, Inc. (TSHA)

Buys

2 · $123.3K

Sells

0 · $0.00

Total Shares Bought

114,111

Total Shares Sold

TSHA Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Aug 16, 2023	Buy	111,111	$0.90	$100.0K	114,111
Feb 3, 2022	Buy	3,000	$7.78	$23.3K	3,000

Related Insiders

Kamran Alam

CHIEF FINANCIAL OFFICER

TSHASell · Feb 4, 2026

Sukumar Nagendran

President and Head of R&D

TSHASell · Jan 23, 2026

Sean P. Nolan

Chief Executive Officer

TSHASell · Jan 23, 2026

Paul B Manning

10% Owner

TSHABuy · May 30, 2025

Explore More Insider Trading Data

TSHA Insider Trading Activity

View all insider trades at Taysha Gene Therapies, Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity